Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China flag China · Delayed Price · Currency is CNY
27.07
+0.18 (0.67%)
Jul 21, 2026, 3:04 PM CST

Guangdong Zhongsheng Pharmaceutical Company Description

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China.

The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops.

It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.
CountryChina
Founded2001
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,757
CEOYong Hong Chen

Contact Details

Address:
Information Industry Park
Dongguan, 523325
China
Phone86 769 8618 8130
Websitezspcl.com

Stock Details

Ticker Symbol002317
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100000HW4
SIC Code2834

Key Executives

NamePosition
Yong Hong ChenChairman and President
Yuchong ZhangVice Chairman and Senior Vice President
Chun Hua LongVice President, Chief Financial Officer, Financial Director and Director
Wei YangBoard Secretary
Rikang LuoVice President
Shuang LiuVice President